BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24836108)

  • 1. The gut microbiome, probiotics, bile acids axis, and human health.
    Jones ML; Tomaro-Duchesneau C; Prakash S
    Trends Microbiol; 2014 Jun; 22(6):306-8. PubMed ID: 24836108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.
    Degirolamo C; Rainaldi S; Bovenga F; Murzilli S; Moschetta A
    Cell Rep; 2014 Apr; 7(1):12-8. PubMed ID: 24656817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
    Joyce SA; Gahan CG
    Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of microbiota and bile acid in liver injury and regeneration.
    Liu HX; Keane R; Sheng L; Wan YJ
    J Hepatol; 2015 Dec; 63(6):1502-10. PubMed ID: 26256437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario.
    Choi SB; Lew LC; Yeo SK; Nair Parvathy S; Liong MT
    Crit Rev Biotechnol; 2015; 35(3):392-401. PubMed ID: 24575869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics--interactions with bile acids and impact on cholesterol metabolism.
    Pavlović N; Stankov K; Mikov M
    Appl Biochem Biotechnol; 2012 Dec; 168(7):1880-95. PubMed ID: 23054820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of probiotics on bile acids in diseases and aging.
    Sivamaruthi BS; Fern LA; Rashidah Pg Hj Ismail DSN; Chaiyasut C
    Biomed Pharmacother; 2020 Aug; 128():110310. PubMed ID: 32504921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition modifies fecal metabolic profiles in mice.
    Zhao Y; Wu J; Li JV; Zhou NY; Tang H; Wang Y
    J Proteome Res; 2013 Jun; 12(6):2987-99. PubMed ID: 23631562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic modulation methods of gut microbiota and gut-liver axis.
    Beyaz Coşkun A; Sağdiçoğlu Celep AG
    Crit Rev Food Sci Nutr; 2022; 62(23):6505-6515. PubMed ID: 33749411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
    Camara-Lemarroy CR; Metz LM; Yong VW
    World J Gastroenterol; 2018 Oct; 24(37):4217-4223. PubMed ID: 30310254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies.
    Yu L; Liu Y; Wang S; Zhang Q; Zhao J; Zhang H; Narbad A; Tian F; Zhai Q; Chen W
    Gut Microbes; 2023; 15(1):2181930. PubMed ID: 36864554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multispecies probiotics complex improves bile acids and gut microbiota metabolism status in an
    Liu W; Li Z; Ze X; Deng C; Xu S; Ye F
    Front Microbiol; 2024; 15():1314528. PubMed ID: 38444809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bile acid a determinant of the gut microbiota on a high-fat diet?
    Yokota A; Fukiya S; Islam KB; Ooka T; Ogura Y; Hayashi T; Hagio M; Ishizuka S
    Gut Microbes; 2012; 3(5):455-9. PubMed ID: 22825495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.